We navigate you through the healthcare market.

Despite criticism and a lack of practical feasibility, the KHAG is adopted.

Early insights into planned OPS changes provide clarity on reimbursement and market access.

CE certification in Europe allows the sale of a medical device; however, it is the reimbursement that determines its market success. In Germany, annual, fixed-schedule procedures dictate the pace and sequence of the steps toward market access and…

The DRG Forum is one of most important conferences in the German hospital sector. Sven Sauermann from Healthcare Heads consulting will be in Berlin and is looking forward to professional discussions on DRG topics, the effects of reforms, and reimbursement…

The German healthcare market is the largest in Europe and one of the most important medtech markets worldwide.

Medical service groups, pre-reimbursements and transformation funds shift incentives in the highly regulated German hospital market.

In their last consultation, the federal government and state governments are said to have agreed on the contents of the Hospital Reform Adjustment Act (KHAG).

In order to successfully enter the German market, it is necessary to be familiar with the relevant framework conditions and to correctly assess the role of the various stakeholders.

Market access for capital-intensive technologies is significantly more difficult than, for example, for implants or consumable supplies.